ANDREW GUGGENHIME

CIK 1230724 · PRESIDENT AND CFO · last filed 2026-03-11

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$8.50M

Companies

6

Total Filings

81

Lifetime Open-Market Net

-$19.04M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PCVX PRESIDENT AND CFO 166,245 $47.46 $7.89M -$17.06M 46 2026-03-11
CRBU Director $1.59 $0 5 2026-02-20
Metacrine, Inc. (MTCR) Delisted Director $0.49 $0 2 2022-09-06
DERM CFO 42,159 $6.34 $267.3K -$1.98M 15 2019-08-19
FACT SVP & CFO 32,090 $10.65 $341.8K $0 5 2010-04-21
PDL BIOPHARMA, INC. (PDLI) Delisted SVP & Chief Financial Officer 13,255 $0 5 2008-12-19

Recent Filings · Page 7 of 9

81 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2017-02-22 DERM Grant (A) $0 EDGAR
2016-11-10 DERM Mixed -$121.0K EDGAR
2016-10-13 DERM Mixed -$314.2K EDGAR
2016-09-20 DERM Mixed -$442.5K EDGAR
2016-09-14 DERM Mixed -$270.2K EDGAR
2016-08-16 DERM Mixed +741 -$14.1K EDGAR
2016-08-12 DERM Mixed -$255.1K EDGAR
2016-07-12 DERM Mixed -$246.4K EDGAR
2016-02-09 DERM Grant (A) $0 EDGAR
2014-10-02 Grant (A) $0
Showing 6170 of 81
Page 7 of 9
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.